What We Do:
The mission of the Division of Epidemiology, Services and Prevention Research is to improve the nation's public health by promoting integrated approaches to understand and address interactions between individuals and environments that contribute to the continuum of problems related to drug use. We will develop scientific knowledge with clear applications to practice and public policy.
Staff Biographies for the Office of the Director:
- Carlos Blanco, M.D., Ph.D. - Division Director
Carlos Blanco, M.D., Ph.D., M.S. is the Director of the Division of Epidemiology, Services, and Prevention Research at the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. Dr. Blanco is a national known expert in the epidemiology and treatment of addictive disorders with and without comorbid disorders. His accomplishments include, among others, a detailed examination of the course and stages of substance use disorders, the development of methods to quantify the generalizability of clinical trials, the development and testing of interventions that combine motivational interviewing with cognitive-behavioral therapy to improve retention and outcome in individuals with addictive disorders, and the creation of a virtual map of psychiatric disorders, based on empirical data, to guide research into the causes of mental disorders. Prior to joining NIDA, Dr. Blanco was Professor of Psychiatry at Columbia University Medical Center and a Research Psychiatrist at the New York State Psychiatric Institute. He is a graduate of Universidad Autónoma de Madrid (Spain) and completed his psychiatry residency at Columbia University, where he also completed a research fellowship. Dr. Blanco has authored over 200 peer-reviewed publications.
- Bethany Griffin Deeds, Ph.D. - Deputy Director
Bethany Deeds was previously the Prevention Branch Chief in the Division of Epidemiology, Services and Prevention Research at the National Institute on Drug Abuse for 3 years. She was also the Deputy Branch Chief within Epidemiology Branch at NIDA for 6 years where she managed the social epidemiology of drug use portfolio with responsibility for the stimulation of geospatial substance use and abuse research, new methods in drug abuse epidemiology, improved measurements of the social environment, social network/social media research and public health law and policy research related to substance use. She is also a member of the Collaborative Research on Addiction (CRAN) Coordinating Committee and is the Program Official for the landmark Adolescent Behavior Cognitive Development (ABCD) Study. Prior to joining NIDA, she has 10 years of prevention experience and was an Assistant Professor in the Department of Pediatrics at the University of Maryland Medical School. Before joining NIDA, Dr. Deeds was an Assistant Professor in the Department of Pediatrics at the University of Maryland Medical School where her research focused on adolescent violence, substance use and HIV prevention. She also served as Director for Connect to Protect: Baltimore, one of 13 national sites affiliated with the Adolescent Trials Network for HIV/AIDS Interventions, investigating how community partnerships can reduce adolescent HIV incidence and prevalence by making structural changes to the environment.
- Meyer D. Glantz, Ph.D. - Associate Director for Science
Dr. Glantz is currently the Associate Director for Science of the Division of Epidemiology and Prevention Research (DESPR) the National Institute on Drug Abuse, National Institutes of Health and the Chief of the Analytic Unit. At NIDA, Dr. Glantz previously served as the Acting Deputy Director of DESPR and the Chief of the Epidemiology Research Branch and the Director of the Etiology Research Program. Prior to coming to NIDA he worked as a researcher and clinician at the Veterans Administration Clinic in Boston. Dr. Glantz is a Fellow of the American Psychological Association and serves as a consultant to and board member of a variety of scientific and professional organizations and publications. He is the author of numerous articles and chapters on substance abuse, drug abuse etiology, cognitive therapy, prevention, and the elderly and has authored several volumes including Vulnerability to Drug Abuse, Biobehavioral Research Approaches to Drug Abuse Etiology, Resilience and Development: Positive Life Adaptations, and Drug Abuse: Origins and Interventions. In addition, he maintains a private clinical practice in the Washington D.C. area, supervises other clinicians, is a lecturer for the Montgomery County Adult Education program and has taught at several area universities. Dr. Glantz received his doctorate from Harvard University in 1979.
- Jorge Vizcaino-Riveros, MPH - Health Specialist
Jorge joined DESPR in 2020 as a Health Specialist. Jorge’s prior work experiences in research at various Boston-area hospitals, in addition to serving as a Peace Corps Volunteer in Paraguay, led him to Boston University School of Public Health, where he earned his Master’s with concentrations in epidemiology and monitoring and evaluation. Jorge received a BS in Dietetics from the University of Delaware.
- Brandin DeChabert - Program Analyst
Brandin DeChabert rejoined DESPR in December 2019 as DESPR’s newly created program/management team leader position after 3 years as a Staff Assistant with NCATS. He previously worked as an External Support Assistant in DESPR from 2009 to 2017. He earned his bachelor’s degree in Sociology in 2000 from Trinity University in San Antonio, Texas.